Inactive Instrument
Quest PharmaTech Inc. Stock Other OTC
Stocks
QPTFF
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.38M 2.44M 2.11M 1.99M 1.81M 231M 3.41M 23.51M 9.13M 118M 9.18M 8.98M 388M | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 4.37M 3.16M 2.72M 2.56M 2.34M 298M 4.4M 30.37M 11.79M 152M 11.85M 11.59M 501M | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -34.61% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -34.61% | +0.12% | - | - | 2.43M | |
| +0.97% | -1.75% | +2.17% | +18.46% | 49.74B | |
| -0.35% | -2.75% | +430.00% | +521.88% | 44.98B | |
| +2.19% | +1.55% | +44.54% | +20.23% | 42.52B | |
| +1.01% | -3.47% | +9.25% | +77.09% | 40.78B | |
| -0.90% | -1.74% | +15.20% | +48.44% | 32.89B | |
| +2.80% | +6.97% | - | - | 17.09B | |
| +1.47% | -4.22% | +25.26% | +123.66% | 16.28B | |
| +1.70% | -1.75% | +12.00% | +28.50% | 14.4B | |
| +3.39% | -0.97% | +81.23% | +43.05% | 13.48B | |
| Average | -2.10% | -2.42% | +77.46% | +110.16% | 30.24B | |
| Weighted average by Cap. | +1.19% | -2.25% | +93.70% | +129.35% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.8M -1.3M -1.12M -1.06M -964K -123M -1.81M -12.52M -4.86M -62.85M -4.89M -4.78M -206M | 5M 3.61M 3.12M 2.93M 2.67M 341M 5.04M 34.75M 13.49M 174M 13.56M 13.26M 573M |
| Net Debt | 795K 574K 495K 467K 425K 54.26M 801K 5.53M 2.14M 27.74M 2.16M 2.11M 91.12M | 986K 712K 614K 579K 527K 67.27M 993K 6.85M 2.66M 34.4M 2.67M 2.62M 113M |
Employees
-
